We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
-23.86%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$2.34B
AUM Growth
-$463M
Cap. Flow
+$326M
Cap. Flow %
13.93%
Top 10 Hldgs %
52.09%
Holding
73
New
17
Increased
17
Reduced
10
Closed
27

Top Buys

Rank Stock Value
1
WELL icon
Welltower
WELL
+$117M
2
EHC icon
Encompass Health
EHC
+$111M
3
AMRN
Amarin Corp
AMRN
+$101M
4
HAE icon
Haemonetics
HAE
+$97.5M
5
BHC icon
Bausch Health
BHC
+$92.1M

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$140M
2
JNJ icon
Johnson & Johnson
JNJ
+$100M
3
HOLX
Hologic
HOLX
+$87.5M
4
HCA icon
HCA Healthcare
HCA
+$65.6M
5
XENT
Intersect ENT, Inc
XENT
+$63.2M

Sector Composition

Rank Sector Weight
1 Healthcare 92.58%
2 Real Estate 5.41%
3 Industrials 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
51
Edwards Lifesciences
EW
$51.7B
– –
-399,630
Closed -$31.1M
GILD icon
52
Gilead Sciences
GILD
$165B
– –
-283,520
Closed -$18.4M
ILMN icon
53
Illumina
ILMN
$28.4B
– –
-149,975
Closed -$48.4M
ISRG icon
54
Intuitive Surgical
ISRG
$134B
– –
-250,650
Closed -$49.4M
JNJ icon
55
Johnson & Johnson
JNJ
$625B
– –
-687,960
Closed -$100M
LLY icon
56
PUT
Eli Lilly
LLY
$1.06T
– –
-100,000
Closed -$13.1M
MRK icon
57
Merck
MRK
$318B
– –
-558,804
Closed -$48.5M
REGN icon
58
Regeneron Pharmaceuticals
REGN
$80.8B
– –
-372,770
Closed -$140M
SRPT icon
59
Sarepta Therapeutics
SRPT
$1.77B
– –
-50,280
Closed -$6.49M
SYK icon
60
Stryker
SYK
$130B
– –
-64,170
Closed -$13.5M
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$126B
– –
-65,860
Closed -$14.4M
XLV icon
62
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
– –
-100,000
Closed -$10.2M
VRAY
63
DELISTED
ViewRay, Inc.
VRAY
– –
-9,477,799
Closed -$40M
ABMD
64
DELISTED
Abiomed Inc
ABMD
– –
-286,710
Closed -$48.9M
AERI
65
DELISTED
Aerie Pharmaceuticals
AERI
– –
-302,290
Closed -$7.31M
CVET
66
PUT
DELISTED
Covetrus, Inc. Common Stock
CVET
– –
-500,000
Closed -$6.6M
CHNG
67
DELISTED
Change Healthcare Inc. Common Stock
CHNG
– –
-2,849,650
Closed -$46.7M
XENT
68
DELISTED
Intersect ENT, Inc
XENT
– –
-2,536,760
Closed -$63.2M
XLRN
69
DELISTED
Acceleron Pharma
XLRN
– –
-322,540
Closed -$17.1M
HMSY
70
DELISTED
HMS Holdings Corp.
HMSY
– –
-463,390
Closed -$13.7M
DERM
71
DELISTED
Dermira, Inc.
DERM
– –
-364,227
Closed -$5.52M
MDCO
72
PUT
DELISTED
Medicines Co
MDCO
– –
-75,000
Closed -$6.37M
ZGNX
73
DELISTED
Zogenix, Inc.
ZGNX
– –
-618,550
Closed -$32.2M
1 2
3

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q1 2020 Portfolio in Review

As of Q1 2020, HealthCor Management held 73 positions worth $2.34B, down 17% from $2.8B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

HealthCor Management deployed $326M of net new capital in Q1 2020, opening 17 new positions and adding to 17 existing holdings. Its largest new stake was Welltower: 1,582,360 shares worth $72.4M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, up from 92% a quarter earlier, followed by Real Estate and Industrials.

On the sell side, the largest reduction was Hologic, an estimated $87.5M trimmed.

  • HealthCor Management's largest Q1 2020 buy was Welltower: 1,582,360 shares worth $72.4M.
  • HealthCor Management added most to Amarin Corp in Q1 2020, an estimated $101M increase.
  • HealthCor Management's biggest Q1 2020 reduction was Hologic, cutting an estimated $87.5M.
  • HealthCor Management fully exited Regeneron Pharmaceuticals in Q1 2020, selling an estimated $140M.
  • HealthCor Management's ten largest holdings make up 52% of its $2.34B portfolio in Q1 2020.
  • HealthCor Management opened 17 new positions and closed 27 in Q1 2020.
  • HealthCor Management's portfolio value fell 17% quarter-over-quarter to $2.34B.

Based on HealthCor Management's 13F filing for Q1 2020, filed 15 May 2020.